Novartis AG
Imidazolepyridine compounds and uses thereof

Abstract:

A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: ##STR00001## wherein A, R.sup.3, R.sup.4, R.sup.6, and R.sup.7 are as defined herein.